Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lensar Inc
(NQ:
LNSR
)
4.720
+0.320 (+7.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lensar Inc
< Previous
1
2
Next >
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
August 08, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union
August 07, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
August 01, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
May 23, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports First Quarter 2024 Results and Provides Business Update
May 09, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 02, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
March 04, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
February 26, 2024
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
November 09, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
November 02, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Second Quarter 2023 Results and Provides Business Update
August 09, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups
July 24, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports First Quarter 2023 Results and Provides Business Update
May 15, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
May 10, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
March 16, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
March 09, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results
February 14, 2023
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Present at Two Upcoming Investor Conferences
November 22, 2022
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022
November 02, 2022
From
LENSAR, Inc.
Via
Business Wire
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
September 08, 2022
From
LENSAR, Inc.
Via
Business Wire
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
August 16, 2022
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
August 08, 2022
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
August 01, 2022
From
LENSAR, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.